article 3 months old

Rockeby Flu Kits Selling To The World

Australia | Apr 11 2006

In a press release this morning, Rockeby Biomed (RBY) has appointed distributors of its avian influenza test kits in Turkey, Palestine, Egypt, UAE and France.

The company has further signed a memorandum of understanding with Pacific Biotech of Thailand to license rights to manufacture the flu kits outside Thailand – with China, where there is a need for post-vaccination screening and surveillance, the main target.

An upfront fee and royalties to Rockeby will help facilitate local manufacture and sales in China, in turn reducing production costs. China is reported to have in excess of four billion chickens alone.

Rockeby sees this as an opportunity to increase margins. Global demand is increasing dramatically and the company is well placed to take advantage. Orders have also now come in from Thailand’s largest poultry producer. Romania has approved the kits.

The Animal Health Division of the World Health Organisation has also added Rockeby’s kit to its list of other bird flu tests. By the end of this year Rockeby expects official certification.

A clinical trial is underway in Hong Kong to comparatively evaluate such tests. Preliminary results are expected some time before June.

To share this story on social media platforms, click on the symbols below.

Click to view our Glossary of Financial Terms

Australian investors stay informed with FNArena – your trusted source for Australian financial news. We deliver expert analysis, daily updates on the ASX and commodity markets, and deep insights into companies on the ASX200 and ASX300, and beyond. Whether you're seeking a reliable financial newsletter or comprehensive finance news and detailed insights, FNArena offers unmatched coverage of the stock market news that matters. As a leading financial online newspaper, we help you stay ahead in the fast-moving world of Australian finance news.